SFE Investment Counsel Purchases 83 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

SFE Investment Counsel boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,412 shares of the medical equipment provider’s stock after buying an additional 83 shares during the period. SFE Investment Counsel’s holdings in Intuitive Surgical were worth $476,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. OFI Invest Asset Management bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $25,000. Baystate Wealth Management LLC increased its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. Headinvest LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $28,000. Stone House Investment Management LLC increased its holdings in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $386.99 on Friday. The company has a market cap of $137.17 billion, a P/E ratio of 74.08, a P/E/G ratio of 5.81 and a beta of 1.36. The stock’s fifty day moving average price is $387.27 and its two-hundred day moving average price is $342.60. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The business’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.00 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 5,041 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $397.07, for a total value of $2,001,629.87. Following the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, VP Fredrik Widman sold 5,041 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ISRG shares. Jefferies Financial Group boosted their target price on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday. Wells Fargo & Company boosted their target price on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Citigroup boosted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Raymond James boosted their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Finally, Royal Bank of Canada boosted their target price on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $378.48.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.